The above findings suggest that the overactivation of ENO-1 has a fibrosis-promoting effect and that cardiomyocyte activation and myocardial fibrosis after MI can be alleviated by inhibiting ENO-1 [119]. Here, ENO1 is linked to myocardial infarction.